UNCY
Unicycive Therapeutics Inc
NASDAQ: UNCY · HEALTHCARE · BIOTECHNOLOGY
$7.66
+6.98% today
Updated 2026-04-30
Market cap
$180.96M
P/E ratio
—
P/S ratio
23.75x
EPS (TTM)
$-1.67
Dividend yield
—
52W range
$4 – $11
Volume
0.5M
Unicycive Therapeutics Inc (UNCY) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $29000.00 | $19000.00 | $204000.00 | $18.74M | $2.82M | $14.19M | $31.67M |
| Cash & equivalents | $25000.00 | $15000.00 | $0.00 | $16.58M | $455000.00 | $9.70M | $26.14M |
| Current assets | $29000.00 | $19000.00 | $204000.00 | $18.41M | $2.64M | $13.40M | $30.95M |
| Total liabilities | $1.24M | $903000.00 | $2.88M | $2.26M | $3.28M | $18.00M | $24.24M |
| Current liabilities | $1.24M | $903000.00 | $2.88M | $2.10M | $3.28M | $17.53M | $24.12M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-1.21M | $-884000.00 | $-2.67M | $16.48M | $-466000.00 | $-3.81M | $7.43M |
| Retained earnings | $-1.49M | $-3.66M | $-5.92M | $-15.94M | $-34.00M | $-64.54M | $-101.27M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |